Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders

Kai Zhang · Huanzhong Liu · Kenji Hashimoto

53 citations0/0 files storedThe British Journal of Psychiatry

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

COVID-19 and Mental Health COVID-19 Clinical Research Studies Treatment of Major Depression

Abstract

Many psychiatric patients have been infected with COVID-19, and patients with COVID-19 may develop psychiatric symptoms after treatment with antiviral drugs. Given the tolerability and minimal P450 interactions, antidepressants (i.e., citalopram, escitalopram etc.), antipsychotics (i.e., olanzapine) and valproate can be considered to be safe in combination with antiviral drugs.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 53 citations exist upstream.

Cited by

2020The impact of the early phase of the COVID-19 pandemic on mental-health services in Europe

Imported from OpenAlex (CC0) — nothing here is generated.